dc.contributor.author | Aas, Christer Frode | |
dc.contributor.author | Vold, Jørn Henrik | |
dc.contributor.author | Skurtveit, Svetlana | |
dc.contributor.author | Odsbu, Ingvild | |
dc.contributor.author | Chalabianloo, Fatemeh | |
dc.contributor.author | Økland, Jan-Magnus | |
dc.contributor.author | Leiva, Rafael Alexander Mo | |
dc.contributor.author | Vickerman, Peter | |
dc.contributor.author | Johansson, Kjell Arne | |
dc.contributor.author | Fadnes, Lars T. | |
dc.date.accessioned | 2023-05-08T10:40:46Z | |
dc.date.available | 2023-05-08T10:40:46Z | |
dc.date.created | 2020-09-29T20:59:06Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | BMJ Open. 2020, 10:e036355 (8), 1-9. | |
dc.identifier.issn | 2044-6055 | |
dc.identifier.uri | https://hdl.handle.net/11250/3066979 | |
dc.language.iso | eng | |
dc.title | On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017 | |
dc.type | Peer reviewed | |
dc.type | Journal article | |
dc.description.version | publishedVersion | |
dc.source.pagenumber | 1-9 | |
dc.source.volume | 10:e036355 | |
dc.source.journal | BMJ Open | |
dc.source.issue | 8 | |
dc.identifier.doi | 10.1136/bmjopen-2019-036355 | |
dc.identifier.cristin | 1835176 | |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |